Home Featured Seattle Life Science VC Plunges 58% to $396MM as Bay Area Funding Holds at $8.3B
FeaturedFinanceIndustry NewsLeasingLife Science

Seattle Life Science VC Plunges 58% to $396MM as Bay Area Funding Holds at $8.3B

Share
Microscope close up
Getty Images For Unsplash+
Share

Seattle life science companies raised only $395.9 million through the third quarter, on pace for the weakest year since at least 2022, as Savills' Q3 2026 data show vacancy rising 150 basis points to 18.9 percent while Bay Area funding and vacancy hold steadier.

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

2026 Pacific Northwest CRE Rising Stars

PNW CRE Rising Stars

Featured Posts


Recent Posts

Related Articles

The New Home Company’s 348-Unit Axiom Apartments Nears Delivery at River Terrace in Tigard

The largest apartment project slated to finish in the Portland metro this...

Seattle Cruise Business Hits Record 330 Calls, $1.2B Impact as MSC and Virgin Voyages Debut

The Port of Seattle closed its 2026 Alaska cruise season with a...

Crusoe’s 46,000 SQFT Key Center Expansion Puts AI at the Front of a Bellevue Market Running Short on Big Class A Blocks

CBRE's third-quarter 2026 Seattle office report places Crusoe Energy Systems' 46,000-square-foot expansion...